At what calcitonin (calcitonin) level should surgery be considered for a child under 5, specifically a girl with a known RET (ret proto-oncogene) mutation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Thyroidectomy in Girls Under 5 with RET Mutations Based on Calcitonin Values

For girls under 5 years with RET mutations, prophylactic total thyroidectomy should be performed by age 5 regardless of calcitonin levels, with immediate intervention indicated if calcitonin becomes elevated or abnormal on stimulation testing. 1

Decision Algorithm Based on RET Mutation Risk Level

Highest Risk Mutations (Level D)

  • RET codons 883,918,922 (MEN 2B)
  • Action: Total thyroidectomy during the first year of life or at diagnosis
  • Rationale: Highest risk of aggressive MTC development 1, 2

High Risk Mutations (Level B)

  • RET codons 609,611,618,620,630,634 (MEN 2A)
  • Action: Total thyroidectomy by age 5 years regardless of calcitonin level
  • Rationale: Earliest reported MTC at age 7 for codon 618 mutations 1, 2

Moderate Risk Mutations (Level A)

  • RET codons 768,790,791,804,891
  • Action: Annual calcitonin testing and ultrasound; thyroidectomy may be deferred if tests normal
  • Rationale: Lower lethality and later onset of MTC 1, 2

Calcitonin-Based Decision Making

  1. Normal Calcitonin + High-Risk Mutation:

    • Proceed with prophylactic thyroidectomy by age 5
    • Don't wait for calcitonin elevation 1, 2
  2. Elevated Basal Calcitonin (>50 pg/mL):

    • Immediate thyroidectomy regardless of age
    • Higher risk of advanced disease and lower surgical cure rate (34.3%) 3
  3. Positive Stimulation Test (Normal Basal, Elevated Stimulated):

    • Immediate thyroidectomy
    • Better surgical cure rate (60%) compared to waiting for basal elevation 3

Surgical Approach Based on Disease Status

  1. Prophylactic Surgery (No Evidence of Disease):

    • Total thyroidectomy alone
    • Consider bilateral central neck dissection (level VI) for MEN 2B 1
  2. With Elevated Calcitonin or Abnormal Ultrasound:

    • Total thyroidectomy
    • Therapeutic ipsilateral or bilateral central neck dissection (level VI) 1
  3. With Tumors >0.5 cm (MEN 2B) or >1.0 cm (MEN 2A):

    • Total thyroidectomy
    • More extensive lymph node dissection (levels II-V) 1

Importance of Early Intervention

The surgical cure rate differs dramatically based on timing:

  • 89% cure rate for early detection ("converters")
  • Only 25% cure rate for symptomatic MTC patients 1, 2

Monitoring Protocol

For girls awaiting surgery or with moderate-risk mutations:

  • Annual calcitonin measurement starting at age 3
  • Annual thyroid ultrasound
  • Screening for pheochromocytoma and hyperparathyroidism starting at age 10 (every 2 years) 1, 2

Important Caveats

  1. Surgeon Selection: Refer to a surgeon and team experienced in pediatric thyroid surgery due to higher risks of complications in very young children 1

  2. Preoperative Screening: Always screen for pheochromocytoma before thyroid surgery to prevent hypertensive crisis 1, 2

  3. False Negatives: Rare cases of MTC without calcitonin elevation exist, so genetic status should guide decision-making more than calcitonin levels 4

  4. Postoperative Management: Normalize (not suppress) TSH with levothyroxine; C-cells lack TSH receptors 1

  5. Variable Penetrance: Some mutations show variable penetrance, but prophylactic surgery is still recommended for high-risk mutations due to potential aggressive behavior 5, 6

The evidence strongly supports early prophylactic thyroidectomy by age 5 for girls with high-risk RET mutations, regardless of calcitonin levels, to maximize survival and quality of life outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medullary Thyroid Carcinoma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.

Thyroid : official journal of the American Thyroid Association, 2004

Research

Medullary Thyroid Carcinoma Associated with Germline RETK666N Mutation.

Thyroid : official journal of the American Thyroid Association, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.